Cargando…

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma

BACKGROUND: The leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins constitute an integral membrane protein family that has three members: LRIG1, LRIG2, and LRIG3. LRIG1 negatively regulates growth factor signaling, but little is known regarding the functions of LRIG2 and LRIG3. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Rondahl, Veronica, Holmlund, Camilla, Karlsson, Terese, Wang, Baofeng, Faraz, Mahmood, Henriksson, Roger, Hedman, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/
https://www.ncbi.nlm.nih.gov/pubmed/24023893
http://dx.doi.org/10.1371/journal.pone.0073635
_version_ 1782282933971714048
author Rondahl, Veronica
Holmlund, Camilla
Karlsson, Terese
Wang, Baofeng
Faraz, Mahmood
Henriksson, Roger
Hedman, Håkan
author_facet Rondahl, Veronica
Holmlund, Camilla
Karlsson, Terese
Wang, Baofeng
Faraz, Mahmood
Henriksson, Roger
Hedman, Håkan
author_sort Rondahl, Veronica
collection PubMed
description BACKGROUND: The leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins constitute an integral membrane protein family that has three members: LRIG1, LRIG2, and LRIG3. LRIG1 negatively regulates growth factor signaling, but little is known regarding the functions of LRIG2 and LRIG3. In oligodendroglial brain tumors, high expression of LRIG2 correlates with poor patient survival. Lrig1 and Lrig3 knockout mice are viable, but there have been no reports on Lrig2-deficient mice to date. METHODOLOGY/PRINCIPAL FINDINGS: Lrig2-deficient mice were generated by the ablation of Lrig2 exon 12 (Lrig2E12). The Lrig2E12-/- mice showed a transiently reduced growth rate and an increased spontaneous mortality rate; 20-25% of these mice died before 130 days of age, with the majority of the deaths occurring before 50 days. Ntv-a transgenic mice with different Lrig2 genotypes were transduced by intracranial injection with platelet-derived growth factor (PDGF) B-encoding replication-competent avian retrovirus (RCAS)-producing DF-1 cells. All injected Lrig2E12+/+ mice developed Lrig2 expressing oligodendroglial brain tumors of lower grade (82%) or glioblastoma-like tumors of higher grade (18%). Lrig2E12-/- mice, in contrast, only developed lower grade tumors (77%) or had no detectable tumors (23%). Lrig2E12-/- mouse embryonic fibroblasts (MEF) showed altered induction-kinetics of immediate-early genes Fos and Egr2 in response to PDGF-BB stimulation. However, Lrig2E12-/- MEFs showed no changes in Pdgfrα or Pdgfrβ levels or in levels of PDGF-BB-induced phosphorylation of Pdgfrα, Pdgfrβ, Akt, or extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). Overexpression of LRIG1, but not of LRIG2, downregulated PDGFRα levels in HEK-293T cells. CONCLUSIONS: The phenotype of Lrig2E12-/- mice showed that Lrig2 was a promoter of PDGFB-induced glioma, and Lrig2 appeared to have important molecular and developmental functions that were distinct from those of Lrig1 and Lrig3.
format Online
Article
Text
id pubmed-3762791
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37627912013-09-10 Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma Rondahl, Veronica Holmlund, Camilla Karlsson, Terese Wang, Baofeng Faraz, Mahmood Henriksson, Roger Hedman, Håkan PLoS One Research Article BACKGROUND: The leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins constitute an integral membrane protein family that has three members: LRIG1, LRIG2, and LRIG3. LRIG1 negatively regulates growth factor signaling, but little is known regarding the functions of LRIG2 and LRIG3. In oligodendroglial brain tumors, high expression of LRIG2 correlates with poor patient survival. Lrig1 and Lrig3 knockout mice are viable, but there have been no reports on Lrig2-deficient mice to date. METHODOLOGY/PRINCIPAL FINDINGS: Lrig2-deficient mice were generated by the ablation of Lrig2 exon 12 (Lrig2E12). The Lrig2E12-/- mice showed a transiently reduced growth rate and an increased spontaneous mortality rate; 20-25% of these mice died before 130 days of age, with the majority of the deaths occurring before 50 days. Ntv-a transgenic mice with different Lrig2 genotypes were transduced by intracranial injection with platelet-derived growth factor (PDGF) B-encoding replication-competent avian retrovirus (RCAS)-producing DF-1 cells. All injected Lrig2E12+/+ mice developed Lrig2 expressing oligodendroglial brain tumors of lower grade (82%) or glioblastoma-like tumors of higher grade (18%). Lrig2E12-/- mice, in contrast, only developed lower grade tumors (77%) or had no detectable tumors (23%). Lrig2E12-/- mouse embryonic fibroblasts (MEF) showed altered induction-kinetics of immediate-early genes Fos and Egr2 in response to PDGF-BB stimulation. However, Lrig2E12-/- MEFs showed no changes in Pdgfrα or Pdgfrβ levels or in levels of PDGF-BB-induced phosphorylation of Pdgfrα, Pdgfrβ, Akt, or extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). Overexpression of LRIG1, but not of LRIG2, downregulated PDGFRα levels in HEK-293T cells. CONCLUSIONS: The phenotype of Lrig2E12-/- mice showed that Lrig2 was a promoter of PDGFB-induced glioma, and Lrig2 appeared to have important molecular and developmental functions that were distinct from those of Lrig1 and Lrig3. Public Library of Science 2013-09-04 /pmc/articles/PMC3762791/ /pubmed/24023893 http://dx.doi.org/10.1371/journal.pone.0073635 Text en © 2013 Rondahl et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rondahl, Veronica
Holmlund, Camilla
Karlsson, Terese
Wang, Baofeng
Faraz, Mahmood
Henriksson, Roger
Hedman, Håkan
Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
title Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
title_full Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
title_fullStr Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
title_full_unstemmed Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
title_short Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
title_sort lrig2-deficient mice are protected against pdgfb-induced glioma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/
https://www.ncbi.nlm.nih.gov/pubmed/24023893
http://dx.doi.org/10.1371/journal.pone.0073635
work_keys_str_mv AT rondahlveronica lrig2deficientmiceareprotectedagainstpdgfbinducedglioma
AT holmlundcamilla lrig2deficientmiceareprotectedagainstpdgfbinducedglioma
AT karlssonterese lrig2deficientmiceareprotectedagainstpdgfbinducedglioma
AT wangbaofeng lrig2deficientmiceareprotectedagainstpdgfbinducedglioma
AT farazmahmood lrig2deficientmiceareprotectedagainstpdgfbinducedglioma
AT henrikssonroger lrig2deficientmiceareprotectedagainstpdgfbinducedglioma
AT hedmanhakan lrig2deficientmiceareprotectedagainstpdgfbinducedglioma